Inventor · disambiguated record
Alex Aimetti
Also filed as: AIMETTI ALEX · AIMETTI ALEX A · AIMETTI ALEX ARTHUR
12 granted patents·13 pending applications·19 citations·filing 2012–2024
87Inventor score
Files withMARINUS PHARMACEUTICALS INC12INVIVO THERAPEUTICS CORP5MASSACHUSETTS INST TECHNOLOGY3IMMEDICA PHARMA US INC2CHILDRENS MEDICAL CENTER1
Top patents by PatentIndex Score
25 records- 0194US12115169B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersMARINUS PHARMACEUTICALS INC·Filed 2024·Granted Oct 15, 2024·3 cites·24 claims
- 0294US11980625B2Ganaxolone for use in treating tuberous sclerosis complexMARINUS PHARMACEUTICALS INC·Filed 2023·Granted May 14, 2024·4 cites·25 claims
- 0394US11701367B2Ganaxolone for use in treating tuberous sclerosis complexMARINUS PHARMACEUTICALS INC·Filed 2022·Granted Jul 18, 2023·4 cites·25 claims
- 0492US11110100B2Ganaxolone for use in treatment of status epilepticusMARINUS PHARMACEUTICALS INC·Filed 2021·Granted Sep 7, 2021·3 cites·21 claims
- 0587US12268696B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersMARINUS PHARMACEUTICALS INC·Filed 2024·Granted Apr 8, 2025·0 cites·22 claims
- 0687US12246026B2Ganaxolone for use in treatment of status epilepticusMARINUS PHARMACEUTICALS INC·Filed 2021·Granted Mar 11, 2025·1 cites·26 claims
- 0784US9994615B2Self-regulated peptide hydrogel for insulin deliveryMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Jun 12, 2018·3 cites·22 claims
- 0884US2025032512A1Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersMARINUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0983US12390477B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersIMMEDICA PHARMA US INC·Filed 2024·Granted Aug 19, 2025·0 cites·22 claims
- 1083US12383564B2Ganaxolone for use in treating tuberous sclerosis complex and seizure disordersIMMEDICA PHARMA US INC·Filed 2024·Granted Aug 12, 2025·0 cites·22 claims
- 1180US2023405021A1Ganaxolone for use in treatment of status epilepticusMARINUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1278US11679117B2Ganaxolone for use in treatment of status epilepticusMARINUS PHARMACEUTICALS INC·Filed 2022·Granted Jun 20, 2023·0 cites·28 claims
- 1377US2024374614A1Ganaxolone for use in treating tuberous sclerosis complexMARINUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1467US10131786B2Poly((lactic-co-glycolic acid)-B-lysine) and process for synthesizing a block copolymer of PLGA {poly(lactic-co-glycolic acid)} and PLL (poly-ϵ-cbz-L-lysine)HARVEY JOHN·Filed 2012·Granted Nov 20, 2018·1 cites·3 claims
- 1565US11266662B2Ganaxolone for use in prophylaxis and treatment of postpartum depressionMARINUS PHARMACEUTICALS INC·Filed 2019·Granted Mar 8, 2022·0 cites·20 claims
- 1661US2014271601A1Crosslinkable trehalose for the covalent incorporation in hydrogels and methods of useMASSACHUSETTS INST TECHNOLOGY·Filed 2014·Application pending·0 cites
- 1760US2023321117A1Use of ganaxolone in treating an epilepsy disorderMARINUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1855US2018015167A1Crosslinkable trehalose for the covalent incorporation in hydrogels and methods of useINVIVO THERAPEUTICS CORP·Filed 2017·Application pending·0 cites
- 1954US2013149318A1Painting the pia, arachnoid, and spinal cord parenchymaINVIVO THERAPEUTICS CORP·Filed 2012·Application pending·0 cites
- 2045US2016067190A1Injectable nano-network gels for diabetes treatmentCHILDRENS MEDICAL CENTER·Filed 2014·Application pending·0 cites
- 2145US2013142781A1Peg based hydrogel for peripheral nerve injury applications and compositions and method of use of synthetic hydrogel sealantsINVIVO THERAPEUTICS CORP·Filed 2012·Application pending·0 cites
- 2241US2017304453A1Thiol-ene functionalized hydrogelsMASSACHUSETTS INST TECHNOLOGY·Filed 2015·Application pending·0 cites
- 2340US2013197189A1Method For Synthesizing A Cyclic Multivalent Peptide Using A Thiol-Mediated ReactionUNIV COLORADO REGENTS·Filed 2012·Application pending·0 cites
- 2436US2017151286A1Compositions and methods for preparing an injectable medium for administration into the central nervous systemINVIVO THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
- 2534US2017151416A1Methods and Systems for Delivery of a Trail of a Therapeutic Substance into an Anatomical SpaceINVIVO THERAPEUTICS CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alex Aimetti files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →